NCT02583165View on ClinicalTrials.gov

A Study in Adult Subjects With Select Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 9, 2015

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions
Advanced Solid Tumors
Interventions
BIOLOGICAL

MEDI1873

Subjects will receive MEDI1873 by intravenous administration

Trial Locations (10)

10032

Research Site, New York

19111

Research Site, Philadelphia

33612

Research Site, Tampa

37203

Research Site, Nashville

55905

Research Site, Rochester

73117

Research Site, Oklahoma City

77521

Research Site, Houston

85054

Research Site, Phoenix

85258

Research Site, Scottsdale

90025

Research Site, Los Angeles

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY